The prion protein and neuronal zinc homeostasis

Trends in Biochemical Sciences

Volumn 28, Issue 8, 2003, Pages 406-410

  Watt, Nicole T ^a   Hooper, Nigel M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; METAL ION; PRION PROTEIN; ZINC ION;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; BRAIN; BRAIN SPONGIOSIS; CELL ACTIVITY; CELL FUNCTION; CELL SURFACE; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; ENDOCYTOSIS; EXPOSURE; EXTRACELLULAR SPACE; HOMEOSTASIS; HUMAN; HYPOTHESIS; INTRACELLULAR SPACE; INTRACELLULAR TRANSPORT; METAL BINDING; MOLECULAR MODEL; NERVE CELL; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS;

EID: 0042658237     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(03)00166-X     Document Type: Article

References (50)

1. Hooper N.M. The biological roles of zinc and families of zinc metalloproteases. Hooper N.M. Zinc Metalloproteases in Health and Disease. 1996;1-21 Taylor & Francis.
2. Berg J.M., Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science. 271:1996;1081-1085.
3. Sun M.K., Alkon D.L. Carbonic anhydrase gating of attention: memory therapy and enhancement. Trends Pharmacol. Sci. 23:2002;83-89.
4. Outten C.E., O'Halloran T.V. Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis. Science. 292:2001;2488-2492.
5. Pauly P.C., Harris D.A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273:1998;33107-33110.
6. Perera W.S.S., Hooper N.M. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr. Biol. 11:2001;519-523.
7. 2+: a novel ionic mediator of neural injury in brain disease. Trends Pharmacol. Sci. 21:2000;395-401.
8. Frederickson C.J. Neurobiology of zinc and zinc-containing neurons. Int. Rev. Neurobiol. 31:1989;145-238.
9. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res. Brain Res. Rev. 34:2000;137-148.
10. 2+ from brain tissue during activity. Nature. 308:1984;734-736.
11. McMahon R.J., Cousins R.J. Mammalian zinc transporters. J. Nutr. 128:1998;667-670.
12. Colvin R.A., et al. Zinc transport in the brain: routes of zinc influx and efflux in neurons. J. Nutr. 130:2000;1484S-1487S.
13. Gaither L.A., Eide D.J. Eukaryotic zinc transporters and their regulation. Biometals. 14:2001;251-270.
14. Gunshin H., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
15. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13363-13383.
16. Brown D.R. Prion and prejudice: normal protein and the synapse. Trends Neurosci. 24:2001;85-90.
17. Viles J.H., et al. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2042-2047.
18. Whittal R.M., et al. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci. 9:2000;332-343.
19. Jackson G.S., et al. Location and properties of metal-binding sites on the human prion protein. Proc. Natl. Acad. Sci. U. S. A. 98:2001;8531-8535.
20. Garnett A.P., Viles J.H. Copper binding to the octarepeats of the prion protein. Affinity, specificity, folding, and cooperativity: insights from circular dichroism. J. Biol. Chem. 278:2003;6795-6802.
21. Brown D.R., et al. The cellular prion protein binds copper in vivo. Nature. 390:1997;684-687.
22. Brown D.R., et al. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J. 19:2000;1180-1186.
23. Qin K., et al. Mapping Cu(II) binding sites in prion proteins by diethyl pyrocarbonate modification and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometric footprinting. J. Biol. Chem. 277:2002;1981-1990.
24. Sokolowska M., et al. Short peptides are not reliable models of thermodynamic and kinetic properties of the N-terminal metal binding site in serum albumin. Eur. J. Biochem. 269:2002;1323-1331.
25. Gonzalez-Iglesias R., et al. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J. Mol. Biol. 319:2002;527-540.
26. Lee K.S., et al. Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J. Neurochem. 79:2001;79-87.
27. Rachidi W., et al. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278:2003;9064-9072.
28. Moir R.D., et al. Mounting evidence for the involvement of zinc and copper in Alzheimer's disease. Eur. J. Clin. Invest. 29:1999;569-570.
29. Herms J., et al. Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19:1999;8866-8875.
30. Waggoner D.J., et al. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275:2000;7455-7458.
31. Shyng S.-L., et al. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 268:1993;15922-15928.
32. Burns C.S., et al. Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry. 41:2002;3991-4001.
33. Hooper N.M. GPI anchors. More than just a membrane anchor. Curr. Biol. 2:1992;617-619.
34. Mouillet-Richard S., et al. Signal transduction through prion protein. Science. 289:2000;1925-1928.
35. Chiarini L.B., et al. Cellular prion protein transduces neuroprotective signals. EMBO J. 21:2002;3317-3326.
36. Beyersmann D., Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals. 14:2001;331-341.
37. Wong B.S., et al. Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities. J. Neurochem. 79:2001;689-698.
38. Thackray A.M., et al. Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem. J. 362:2002;253-258.
39. Jobling M.F., et al. Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126. Biochemistry. 40:2001;8073-8084.
40. Somerville R.A. TSE agent strains and PrP: reconciling structure and function. Trends Biochem. Sci. 27:2002;606-612.
41. Wadsworth J.D.F., et al. Strain-specific prion-protein conformation determined by metal ions. Nat. Cell Biol. 1:1999;55-59.
42. Bush A.I., et al. A novel zinc(II) binding site modulates the function of the βA4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268:1993;16109-16112.
43. Atwood C.S., et al. Characterization of copper interactions with alzheimer amyloid β peptides: identification of an attomolar-affinity copper binding site on amyloid β1-42. J. Neurochem. 75:2000;1219-1233.
44. Cuajungco M.P., et al. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 275:2000;19439-19442.
45. Bush A.I., et al. Modulation of Aβ adhesiveness and secretase site cleavage by zinc. J. Biol. Chem. 269:1994;12152-12158.
46. Lee J.Y., et al. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7705-7710.
47. Cherny R.A., et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 30:2001;665-676.
48. Regland B., et al. Treatment of Alzheimer's disease with clioquinol. Dement. Geriatr. Cogn. Disord. 12:2001;408-414.
49. Lyons T.J., et al. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc. Natl. Acad. Sci. U. S. A. 93:1996;12240-12244.
50. Crow J.P., et al. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69:1997;1936-1944.